16
Sep
2021
16:00
BST
16:00
CET
Webinar
When Disruptive Innovation Transforms Into Established AF Therapy: Reality check With 1 Million Patients Treated Using Medtronic Cryoablation Technology
-
Likes:
8
Overview
Experts in electrophysiology will present how the Arctic Front™ Cardiac Cryoablation Catheter System transformed from a disruptive innovation into an established AF therapy and showcase the latest clinical evidence.
The presenters will each draw on their clinical experience, for an in-depth discussion on improvements and patient safety in Cryoballoon AF ablation. Finally, the faculty will share practical advice from the mission towards a risk-free AF ablation with Cryoballoon.
The first Arctic Front™ Cardiac Cryoablation procedure took place in 2005, and since then, over 1,000,000 patients have been treated with Medtronic Cryoablation worldwide. The efficiency benefits of this unique single-shot therapy are obvious and well documented in more than 1,200 peer-reviewed scientific articles. The results of the landmark FIRE AND ICE, CRYO4PERSISTENT AF and EARLY-AF trials highlight an important global shift to value-based healthcare, measured by the ability to standardize the index PVI procedure. The impact on patient outcomes as well as the economic value for the global healthcare systems is significant.
Faculty:
Karl-Heinz Kuck
Gian-Battista Chierchia
Ross Hunter
This webinar is supported by:
Agenda
Key Learning Objectives
- Journey how Arctic Front™ Cardiac Cryoablation Catheter System transformed from a disruptive innovation into an established AF therapy
- Latest evidence updates on Medtronic Cryoballoon ablation therapy developed from different perspectives
- Cryo biophysics and patient tailored AF treatment with Arctic Front™ Cardiac Cryoablation Catheter System
- Safety of AF ablation therapy with Medtronic Cryoballoon
Target Audience
- Cardiac electrophysiologists and allied health professionals performing and assisting during Cryoballoon AF ablation procedures.
- Healthcare professionals using alternative AF ablation techniques.
- Referring healthcare professionals treating AF patients will also find this topical.
Faculty Biographies
Karl-Heinz Kuck
Prof Karl-Heinz Kuck is the Medical Director at LANS Cardio Hamburg. For many years, he was head of the Department of Cardiology at the Asklepios Klinik St. Georg in Hamburg.
Ross Hunter
Personal History
Professor Ross Jacob Hunter was born in 1977 in the UK. He is a Consultant Cardiologist specialising in arrhythmia management and the clinical lead for AF services at The Barts Heart Centre.3
Gian-Battista Chierchia
Prof Chierchia has been Director of the Atrial Fibrillation Program at the Heart Rhythm Management Institute of the Vrije Universtair Ziekenhuis of Brussels, directed by Prof Pedro Brugada, since 2007. He completed his training at the University of Milan, Italy.